Armata Pharmaceuticals Inc logo

Armata Pharmaceuticals Inc

AMEX:ARMP (USA)  
$ 1.46 -0.09 (-5.81%) 11:10 PM EST
P/E:
At Loss
P/B:
1.46
Market Cap:
$ 52.77M
Enterprise V:
$ 86.73M
Volume:
8.87K
Avg Vol (2M):
19.08K
Also Trade In:
Volume:
8.87K
Market Cap $:
52.77M
PE Ratio:
At Loss
Avg Vol (2M):
19.08K
Enterprise Value $:
86.73M
PB Ratio:
1.46

Business Description

Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. It is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Further, the company is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset 0.38
Debt-to-Equity 1.35
Debt-to-EBITDA -1.36
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.55
9-Day RSI 26.63
14-Day RSI 31.66
6-1 Month Momentum % -48.37
12-1 Month Momentum % -52.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.09
Quick Ratio 1.09
Cash Ratio 0.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -53.9

Financials (Next Earnings Date:2023-05-12 Est.)

ARMP's 30-Y Financials

How Armata Pharmaceuticals Inc (ARMP) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:ARMP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.09
Beta 0.63
Volatility % 160.13
14-Day RSI 31.66
14-Day ATR ($) 0.278708
20-Day SMA ($) 2.118
12-1 Month Momentum % -52.61
52-Week Range ($) 0.8311 - 5.79
Shares Outstanding (Mil) 36.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Armata Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Armata Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

Armata Pharmaceuticals Inc Frequently Asked Questions

What is Armata Pharmaceuticals Inc(ARMP)'s stock price today?
The current price of ARMP is $1.46. The 52 week high of ARMP is $5.79 and 52 week low is $0.83.
When is next earnings date of Armata Pharmaceuticals Inc(ARMP)?
The next earnings date of Armata Pharmaceuticals Inc(ARMP) is 2023-05-12 Est..
Does Armata Pharmaceuticals Inc(ARMP) pay dividends? If so, how much?
Armata Pharmaceuticals Inc(ARMP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1